The care of the multiple sclerosis (MS) patient, is optimized by providing comprehensive services across healthcare providers, through coordinated patient support programs (PSPs). This program reviews the drivers of value in MS, the benefits of coordinated care, and how the private sector/pharmaceutical manufacturers can help drive value at the patient and healthcare professional level.
This program is supported by Pharmascience